Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic

Archives of Pediatrics and Adolescent Medicine

Volumn 161, Issue 6, 2007, Pages 603-606

  Radhakrishnan, Dhenuka K ^a   Corey, Mary ^b   Dell, Sharon D ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; BACTERIUM CULTURE; BODY MASS; CANADA; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; GROUPS BY AGE; HOME; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY; PEDIATRIC HOSPITAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; SAMPLING; SPUTUM ANALYSIS;

ADOLESCENT; AGE FACTORS; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; SEX FACTORS; SPECIMEN HANDLING; SPUTUM;

EID: 34249937399     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.161.6.603     Document Type: Article

References (16)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168:918-951.
2. Jung A, Kleinau I, Schonian G, et al. Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J. 2002;20:1457-1463.
3. Thomassen MJ, Klinger JD, Badger SJ, van Heeckeren DW, Stern RC. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr. 1984;104:352-356.
4. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol. 1996;21:267-275.
5. Ramsey BW, Wentz KR, Smith AL, et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis. 1991;144:331-337.
6. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999;28:321-328.
7. Taylor L, Corey M, Matlow A, Sweezey NB, Ratjen F. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis. Pediatr Pulmonol. 2006;41:839-843.
8. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
9. Subbarao P, Lebecque P, Corey M, Coates AL. Comparison of spirometric reference values. Pediatr Pulmonol. 2004;37:515-522.
10. National Center for Health Statistics. 2000 CDC growth charts: United States. http: //www.cdc.gov/growthcharts/. Accessed October 2, 2006.
11. Henig NR, Tonelli MR, Pier MV, Burns JL, Aitken ML. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax. 2001;56:306-311.
12. De Boeck K, Alifier M, Vandeputte S. Sputum induction in young cystic fibrosis patients. Eur Respir J. 2000;16:91-94.
13. Ho SA, Ball R, Morrison LJ, Brownlee KG, Conway SP. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol. 2004;38:82-87.
14. Suri R, Marshall LJ, Wallis C, Metcalfe C, Shute JK, Bush A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol. 2003;35:309-313.
15. Pai VB, Nahata MC. Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Pediatr Pulmonol. 2001;32:314-327.
16. Cunningham S, McColm JR, Mallinson A, Boyd I, Marshall TG. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. Pediatr Pulmonol. 2003;36:43-48.